BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12593901)

  • 1. A randomized controlled trial of coil removal prior to treatment of pelvic inflammatory disease.
    Altunyurt S; Demir N; Posaci C
    Eur J Obstet Gynecol Reprod Biol; 2003 Mar; 107(1):81-4. PubMed ID: 12593901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease.
    Heystek M; Ross JD;
    Int J STD AIDS; 2009 Oct; 20(10):690-5. PubMed ID: 19815913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in the clinical cure rate of outpatient management of pelvic inflammatory disease following a change in therapy.
    Piyadigamage A; Wilson J
    Sex Transm Infect; 2005 Jun; 81(3):233-5. PubMed ID: 15923292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecundity and morbidity following acute pelvic inflammatory disease treated with doxycycline and metronidazole.
    Heinonen PK; Leinonen M
    Arch Gynecol Obstet; 2003 Oct; 268(4):284-8. PubMed ID: 14504870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized Controlled Trial of Ceftriaxone and Doxycycline, With or Without Metronidazole, for the Treatment of Acute Pelvic Inflammatory Disease.
    Wiesenfeld HC; Meyn LA; Darville T; Macio IS; Hillier SL
    Clin Infect Dis; 2021 Apr; 72(7):1181-1189. PubMed ID: 32052831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of injection placentrex and conventional therapy in treatment of pelvic inflammatory disease.
    Garg R; Zahra F; Chandra JA; Vatsal P
    J Indian Med Assoc; 2008 Jul; 106(7):463, 467. PubMed ID: 18975504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic inflammatory disease in the adolescent: understanding diagnosis and treatment as a health care provider.
    Woods JL; Scurlock AM; Hensel DJ
    Pediatr Emerg Care; 2013 Jun; 29(6):720-5. PubMed ID: 23714759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute pelvic inflammatory disease: comparison of therapeutic protocols].
    Balbi G; Piscitelli V; Di Grazia F; Martini S; Balbi C; Cardone A
    Minerva Ginecol; 1996; 48(1-2):19-23. PubMed ID: 8750486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPs should be vigilant for pelvic inflammatory disease.
    Soleymani majd H; Ismail L; Currie I
    Practitioner; 2011 Mar; 255(1738):15-8, 2. PubMed ID: 21510504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained Simultaneous Delivery of Metronidazole and Doxycycline From Polycaprolactone Matrices Designed for Intravaginal Treatment of Pelvic Inflammatory Disease.
    Pathak M; Coombes AGA; Ryu B; Cabot PJ; Turner MS; Palmer C; Wang D; Steadman KJ
    J Pharm Sci; 2018 Mar; 107(3):863-869. PubMed ID: 29100864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ciprofloxacin/metronidazole vs. cefoxitin/doxycycline: comparison of two therapy schedules for treatment of acute pelvic infection].
    Fischbach F; Deckardt R; Graeff H
    Geburtshilfe Frauenheilkd; 1994 Jun; 54(6):337-40. PubMed ID: 8088489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing PID--getting the balance right.
    Marks C; Tideman RL; Estcourt CS; Smart S; Page J; Wagner K; Mindel A
    Int J STD AIDS; 2000 Aug; 11(8):545-7. PubMed ID: 10990340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.
    Ness RB; Soper DE; Holley RL; Peipert J; Randall H; Sweet RL; Sondheimer SJ; Hendrix SL; Amortegui A; Trucco G; Songer T; Lave JR; Hillier SL; Bass DC; Kelsey SF
    Am J Obstet Gynecol; 2002 May; 186(5):929-37. PubMed ID: 12015517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease.
    Heinonen PK; Teisala K; Miettinen A; Aine R; Punnonen R; Grönroos P
    Scand J Infect Dis Suppl; 1989; 60():66-73. PubMed ID: 2756353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial.
    Ness RB; Trautmann G; Richter HE; Randall H; Peipert JF; Nelson DB; Schubeck D; McNeeley SG; Trout W; Bass DC; Soper DE
    Obstet Gynecol; 2005 Sep; 106(3):573-80. PubMed ID: 16135590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of pelvic inflammatory disease.
    Cunha BA
    Clin Pharm; 1990 Apr; 9(4):275-85. PubMed ID: 2184973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating pelvic inflammatory disease with doxycycline and metronidazole or penicillin and metronidazole.
    Heinonen PK; Teisala K; Punnonen R; Aine R; Lehtinen M; Miettinen A; Paavonen J
    Genitourin Med; 1986 Aug; 62(4):235-9. PubMed ID: 3089909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous and oral ciprofloxacin in the treatment of proven pelvic inflammatory disease. A comparison with doxycycline and metronidazole.
    Heinonen PK; Teisala K; Aine R; Miettinen A
    Am J Med; 1989 Nov; 87(5A):152S-156S. PubMed ID: 2589360
    [No Abstract]   [Full Text] [Related]  

  • 19. Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review.
    Tepper NK; Steenland MW; Gaffield ME; Marchbanks PA; Curtis KM
    Contraception; 2013 May; 87(5):655-60. PubMed ID: 23040135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial.
    Savaris RF; Teixeira LM; Torres TG; Edelweiss MI; Moncada J; Schachter J
    Obstet Gynecol; 2007 Jul; 110(1):53-60. PubMed ID: 17601896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.